Literature DB >> 22172423

Protein aggregation in congenital myopathies.

Hans H Goebel1, Astrid Blaschek.   

Abstract

Protein aggregation in congenital myopathies may be encountered among different myofibrillar myopathies such as granulofilamentous myopathy, cytoplasmic body myopathy, or spheroid body myopathy, which are designated as αB crystallinopathy, desminopathy, and myotilinopathy, respectively, according to the respective mutant proteins. Caps in cap disease and reducing bodies in reducing body myopathy were disclosed to contain numerous proteins. The multitude of diverse proteins aggregating within muscle fibers suggests impaired extralysosomal degradation of proteins, a disturbance of catabolism. The lack of different proteins accruing, but the mutant ones at an early age of affected patients in actin filament aggregating myopathy (AFAM) and hyaline body myopathy (HBM), suggests defects in maturation of sarcomeres and failure to integrate the possible mutant proteins, sarcomeric actin and heavy chain myosin in AFAM and HBM, a disturbance of anabolic metabolism.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22172423     DOI: 10.1016/j.spen.2011.10.009

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  9 in total

Review 1.  Myofibrillar myopathies: new developments.

Authors:  Montse Olivé; Rudolf A Kley; Lev G Goldfarb
Journal:  Curr Opin Neurol       Date:  2013-10       Impact factor: 5.710

2.  Hotspots of age-related protein degradation: the importance of neighboring residues for the formation of non-disulfide crosslinks derived from cysteine.

Authors:  Michael G Friedrich; Zhen Wang; Aaron J Oakley; Kevin L Schey; Roger J W Truscott
Journal:  Biochem J       Date:  2017-07-11       Impact factor: 3.857

Review 3.  Pathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focus.

Authors:  Gianina Ravenscroft; Nigel G Laing; Carsten G Bönnemann
Journal:  Brain       Date:  2014-12-31       Impact factor: 13.501

4.  Mutual dependence between tropomodulin and tropomyosin in the regulation of sarcomeric actin assembly in Caenorhabditis elegans striated muscle.

Authors:  Shoichiro Ono; Mario Lewis; Kanako Ono
Journal:  Eur J Cell Biol       Date:  2022-03-15       Impact factor: 6.020

5.  Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.

Authors:  Manish K Gupta; James Gulick; Ruijie Liu; Xuejun Wang; Jeffery D Molkentin; Jeffrey Robbins
Journal:  Circ Res       Date:  2014-08-05       Impact factor: 17.367

6.  A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates.

Authors:  Daniela Rossi; Bianca Vezzani; Lucia Galli; Cecilia Paolini; Luana Toniolo; Enrico Pierantozzi; Simone Spinozzi; Virginia Barone; Elena Pegoraro; Luca Bello; Giovanna Cenacchi; Gaetano Vattemi; Giuliano Tomelleri; Giulia Ricci; Gabriele Siciliano; Feliciano Protasi; Carlo Reggiani; Vincenzo Sorrentino
Journal:  Hum Mutat       Date:  2014-09-10       Impact factor: 4.878

7.  KLHL41 stabilizes skeletal muscle sarcomeres by nonproteolytic ubiquitination.

Authors:  Andres Ramirez-Martinez; Bercin Kutluk Cenik; Svetlana Bezprozvannaya; Beibei Chen; Rhonda Bassel-Duby; Ning Liu; Eric N Olson
Journal:  Elife       Date:  2017-08-09       Impact factor: 8.140

8.  Human protein aging: modification and crosslinking through dehydroalanine and dehydrobutyrine intermediates.

Authors:  Zhen Wang; Brian Lyons; Roger J W Truscott; Kevin L Schey
Journal:  Aging Cell       Date:  2013-11-19       Impact factor: 9.304

9.  Generation of desminopathy in rats using CRISPR-Cas9.

Authors:  Henning T Langer; Agata A Mossakowski; Brandon J Willis; Kristin N Grimsrud; Joshua A Wood; Kevin C K Lloyd; Hermann Zbinden-Foncea; Keith Baar
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-09-07       Impact factor: 12.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.